Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Appointment of Non-Executive Director

9 Feb 2024 07:00

RNS Number : 5627C
Itaconix PLC
09 February 2024
 

Itaconix plc

("Itaconix" or the "Company")

Appointment of Non-Executive Director

Itaconix (AIM: ITX) (OTCQB: ITXXF), a leading innovator in sustainable plant-based polymers used to decarbonise everyday consumer products, is pleased to announce the appointment of Jonathan Brooks to the Board as an independent Non-Executive Director.

Jonathan is recently retired from the European law firm Fieldfisher LLP where he was a Partner in its highly regarded Equity Capital Markets practice. Prior to joining Fieldfisher, he was a Partner and Head of the Capital Markets Group at Maclay Murray & Spens LLP, having qualified as a solicitor and subsequently becoming a Partner at Boodle Hatfield LLP.

With over 35 years of experience, Jonathan has acted for clients in a diverse range of industries, including technology, materials, healthcare, natural resources, renewable energy, and financial services. His experience extends across key corporate growth activities, serving as a valued advisor in numerous IPOs, fundraisings, and venture capital investments. He has managed transactions and advised on legal, regulatory, corporate governance and sustainability matters for a range of high-growth companies in the global equity capital markets.

The appointment of Jonathan as a Non-Executive Director further strengthens Itaconix's leadership team, bringing valuable London Stock Exchange and international equity capital markets experience to further build the Company's foundation for continued growth.

John R. Shaw, CEO of Itaconix, commented:£

"It is a pleasure to welcome Jonathan to our Board. Our CFO Laura Denner and I have worked closely with Jonathan as our trusted counsel and advisor on many critical advances in Itaconix's development and growth. We are excited to embed his knowledge and understanding of fast-growing companies and equity capital markets into our leadership, our governance, and our plans for the future. We look forward to his valuable contributions as we continue to innovate, and execute on our next stage of growth."

Regulatory disclosures

Full name: Jonathan Paul Brooks

Age: 60

Historic directorships and partnerships in previous 5 years:

Company name

Position

Date ceased

Fieldfisher LLP

Partner

30 June 2023

FFW 1001 Limited

Director

2 February 2021

There is no further information to be disclosed in relation to the director appointment pursuant to Rule 17 and Schedule 2, paragraph (g) of the AIM Rules.

- Ends -

 

Itaconix plc

+1 603 775-4400

John R. Shaw / Laura Denner

Belvedere Communications 

+44 (0)20 7653 8702

John West / Llew Angus

Canaccord Genuity - Nominated Adviser and Sole Broker

+44 (0) 20 7523 8000

Adam James / Harry Pardoe

About Itaconix

Itaconix uses its proprietary plant-based polymer technology platform to produce and sell specialty ingredients that improve the safety, performance, and sustainability of consumer products.? The Company's current ingredients are enabling and leading new generations of products in cleaning, hygiene, and beauty.

www.itaconix.com?

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEANAPEDALEFA

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.